Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stamping out cancer.

U Sanyal1

  • 1Department of Anticancer Drug Development, Chittaranjan National Cancer Institute, Calcutta 700026, India. utpalsanyal@hotmail.com

British Journal of Cancer
|December 17, 2003
PubMed
Summary
This summary is machine-generated.

Anticancer stamps raise awareness and funds for cancer research and treatment. This review covers oncophilately, celebrating 75 years since the first anticancer stamp was issued in 1928.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro and in vivo evaluation of 2-chloroethylnitrosourea derivatives as antitumor agents.

Experimental oncology·2015
Same author

Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour models.

Cancer letters·2008
Same author

Evaluation of dimethoxydop-NU as a novel anti-tumor agent.

Journal of experimental & clinical cancer research : CR·2008
Same author

Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.

Experimental oncology·2006
Same author

Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.

Acta poloniae pharmaceutica·2004
Same author

Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.

Journal of experimental & clinical cancer research : CR·2003

Area of Science:

  • Oncology
  • Philately
  • Public Health

Background:

  • Cancer remains a significant global health challenge, with millions of new cases and deaths annually.
  • Prevention and early detection (down staging) are crucial for controlling cancer.
  • The year 2003 marks the 75th anniversary of the first anticancer stamp issuance in 1928.

Purpose of the Study:

  • To provide a timely review of the field of oncophilately.
  • To highlight the role of anticancer stamps in public awareness and fundraising for cancer research and treatment.

Main Methods:

  • Review of historical data on anticancer stamp issuance.
  • Analysis of the impact of stamps on cancer awareness and fundraising.
  • Exploration of the intersection of philately and cancer advocacy.

Related Experiment Videos

Main Results:

  • Anticancer stamps have been issued since 1928, serving as an educational tool.
  • These stamps contribute to raising awareness and generating funds for cancer initiatives.
  • The 75th anniversary provides an opportune moment to assess the field of oncophilately.

Conclusions:

  • Oncophilately is a valuable, albeit niche, tool in the broader fight against cancer.
  • Continued support and recognition of anticancer stamps can enhance their contribution to public health efforts.
  • The historical significance and ongoing relevance of anticancer stamps warrant further attention.